CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | July/August 2018

An Interview With Marco Barbanti, MD

Dr. Barbanti discusses the background of the FAST-TAVI study, MitraClip implantation, and addressing CAD in patients undergoing TAVI.

cit | Article | March/April 2018

Trends in European TAVI Practice

Current application of TAVI in Europe.

By Giuliano Costa, MD; Marco Barbanti, MD; and Corrado Tamburino, MD, PhD

cit | Article | September/October 2018

CT Assessment Before TMVR

Moderator: Dee Dee Wang, MD, FACC, FASE, FSCCT
Panel: Mayra Guerrero, MD, and Marco Barbanti, MD

cit | Article | March/April 2017

Current TAVR Devices

Technical characteristics and evidence to date for FDA- and CE Mark-approved valves.

By Denise Todaro, MD; Andrea Picci, MD; and Marco Barbanti, MD

Advertisement

Advertisement

cit | Article | July/August 2019

PFO Closure: Status Update and New Devices

A review of updated trial data, treatment diagnosis and indications, and approved devices.

By Francesco Dipasquale, MD; Sebastiano Immè, MD; and Marco Barbanti, MD

cit | Article | January/February 2022

Atrial Septal Defects and Patent Foramen Ovale: Current Data Update

Primary clinical manifestations associated with PFO and ASD and their therapeutic implications.

By Marilena Di Salvo, MD; Marco Monte, MD; and Marco Barbanti, MD

cit | News | September 17, 2015

RenalGuard Studied for Prevention of Acute Kidney Injury in TAVR Patients

September 18, 2015—Marco Barbanti, MD, et al published findings from the PROTECT-TAVI study that was conducted to investigate the effect of the RenalGuard system (PLC Medical Systems) on prevention of acute kidney injury (AKI) in patients undergoing transcatheter aortic valve replacement (TAVR).

cit | News | July 8, 2019

Final 5-Year OBSERVANT Results Compare TAVR and SAVR

July 9, 2019—Five-year outcomes from the Italian OBSERVANT study were published online by Marco Barbanti, MD, et al in Circulation: Cardiovascular Interventions.

cit | News | August 10, 2017

Study Evaluates Optimized Screening of CAD With Invasive Coronary Angiography and Ad Hoc PCI During TAVR

August 11, 2017—In a study published online in Circulation: Cardiovascular Interventions, Marco Barbanti, MD, et al sought to describe an optimized approach to coronary artery disease (CAD) screening and management in patients undergoing transcatheter aortic valve replacement (TAVR).

cit | Article | September/October 2018

Challenging Cases: What Would You Do?

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Shakeel A. Qureshi, MD, FRCP, FRCPCH

cit | Article | March/April 2018

Worldwide Trends in TAVR

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC

cit | Article | March/April 2017

TAVR: Insights and Perspectives

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC

cit | Article | July/August 2019

Contemporary Catheter-Based Structural Heart and Vascular Access Closure Options

By Rahul Sharma, MD, FACP, FACC, FSCAI, and Nicolas M. Van Mieghem, MD, PhD, FACC, FESC

cit | News | January 25, 2016

European STRENGTH Trial Will Evaluate Long-Term Impact of RenalGuard Therapy in Patients at High Risk for CI-AKI

January 26, 2016—RenalGuard Solutions, Inc. announced that the STRENGTH trial will begin later this year.

cit | Article | July/August 2018

Considerations of Mitral and Tricuspid Transcatheter Therapies

By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Azeem Latib, MD

cit | Article | January/February 2022

Contemporary PCI and Structural Heart

By Rasha Al-Lamee, MD, and Rahul Sharma, MD

Funding for this supplement provided by Medtronic

cit | Article | November/December 2016 Supplement

Building an Efficient TAVR Program

By Sandeep M. Patel, MD; J. Brandon Elmore, MD; Edwin G. Avery, MD; Marco A. Costa, MD, PhD; Alan Markowitz, MD; Angela Davis, RN; and Guilherme F. Attizzani, MD; on behalf of The Valve Structural Heart Disease Intervention Center, Harrington Heart and Vascular Institute, Cleveland, OH

cit | Article | September/October 2024

Aortic Regurgitation Frontier: Management Options and Future Directions

Epidemiology and pathophysiology considerations for aortic regurgitation, early results and challenges with off-label and dedicated technology, and innovation needs.

By Mohammed Ahmed, MD; Nishath Quader, MD; Marc Sintek, MD; Tsuyoshi Kaneko, MD; and Alan Zajarias, MD

cit | Article | May/June 2017

Point/Counterpoint: Does the United States Have Enough TAVR Centers?

By Paul J. Pearson, MD, PhD, and D. Craig Miller, MD

cit | Article | March/April 2017

Making the Most of CT in TAVR Planning

From clinical research to standard-of-care procedural planning.

By Hasan Jilaihawi, MD


1
2

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button